X
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
USA (Orange Book)
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
Annual Reports
0
36
PharmaCompass offers a list of Mafenide API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Mafenide manufacturer or Mafenide supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Mafenide manufacturer or Mafenide supplier.
PharmaCompass also assists you with knowing the Mafenide API Price utilized in the formulation of products. Mafenide API Price is not always fixed or binding as the Mafenide Price is obtained through a variety of data sources. The Mafenide Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A AM20050421 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of AM20050421, including repackagers and relabelers. The FDA regulates AM20050421 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. AM20050421 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of AM20050421 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A AM20050421 supplier is an individual or a company that provides AM20050421 active pharmaceutical ingredient (API) or AM20050421 finished formulations upon request. The AM20050421 suppliers may include AM20050421 API manufacturers, exporters, distributors and traders.
click here to find a list of AM20050421 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A AM20050421 DMF (Drug Master File) is a document detailing the whole manufacturing process of AM20050421 active pharmaceutical ingredient (API) in detail. Different forms of AM20050421 DMFs exist exist since differing nations have different regulations, such as AM20050421 USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A AM20050421 DMF submitted to regulatory agencies in the US is known as a USDMF. AM20050421 USDMF includes data on AM20050421's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The AM20050421 USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of AM20050421 suppliers with USDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing AM20050421 as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for AM20050421 API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture AM20050421 as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain AM20050421 and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a AM20050421 NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of AM20050421 suppliers with NDC on PharmaCompass.
AM20050421 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of AM20050421 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right AM20050421 GMP manufacturer or AM20050421 GMP API supplier for your needs.
A AM20050421 CoA (Certificate of Analysis) is a formal document that attests to AM20050421's compliance with AM20050421 specifications and serves as a tool for batch-level quality control.
AM20050421 CoA mostly includes findings from lab analyses of a specific batch. For each AM20050421 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
AM20050421 may be tested according to a variety of international standards, such as European Pharmacopoeia (AM20050421 EP), AM20050421 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (AM20050421 USP).
Market Place
